This HTML5 document contains 131 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34546077
rdf:type
wikibase:Item
schema:description
article scientifique (publié 2004) vědecký článek 2004년 논문 2004 թվականի մարտին հրատարակված գիտական հոդված мақолаи илмӣ научна статия სამეცნიერო სტატია 2004年论文 2004 թուականի Մարտին հրատարակուած գիտական յօդուած artículo científico publicado en 2004 سائنسی مضمون 2004年論文 מאמר מדעי vedecký článok tieteellinen artikkeli artikull shkencor videnskabelig artikel (udgivet 2004) 2004年论文 mokslinis straipsnis artigo científico (publicado na 2004) مقالة علمية vitenskapelig artikkel bilimsel makale 2004年の論文 artykuł naukowy 2004年论文 artigo científico scienca artikolo naučni članak наукова стаття, опублікована в березні 2004 articolo scientifico 2004年论文 2004年論文 บทความทางวิทยาศาสตร์ 2004年論文 wetenschappelijk artikel scientific article vitskapeleg artikkel επιστημονικό άρθρο article científic article scientific научни чланак teaduslik artikkel artículu científicu espublizáu en 2004 vetenskaplig artikel 2004 nî lūn-bûn artigo científico (publicado na 2004) научная статья 2004年论文 tudományos cikk wissenschaftlicher Artikel 2004年論文 bài báo khoa học ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ artikulong pang-agham articol științific 2004年論文 2004年论文 مقالهٔ علمی научни чланак
p:P577
wds:Q34546077-CC8FD064-3AE0-4AE1-811D-8E57FE704582
wdt:P577
2004-03-01T00:00:00Z
p:P2093
wds:Q34546077-7DF50AD6-9D11-441E-8821-19248E1AFA46 wds:Q34546077-6FD196C3-B8A7-4422-8417-9AD1DF77F85E wds:Q34546077-97C3EA2B-4A09-4F2A-B9CC-F2C417F6E02C wds:Q34546077-893B853C-C2A7-4961-A23F-A67ECAA5AB9D wds:Q34546077-337539CC-2331-47F9-8753-002B292927A0 wds:Q34546077-3EF7B92A-E746-472B-BFAE-2D7DF7E73AC0 wds:Q34546077-23B30608-5898-4C44-9774-BE27313B3F5D wds:Q34546077-63C359D0-862F-4518-B7ED-1E8D633CF156 wds:Q34546077-447428C8-C206-441F-8CA1-82A94AFF381A wds:Q34546077-1AFA3BC7-5E8B-4DDF-89DC-4E582039DA7D wds:Q34546077-2044AEF0-0A79-4CA2-87C5-63425AA93899 wds:Q34546077-CF8FA272-8C74-4593-B870-3911C26059C6 wds:Q34546077-AF99DF97-4DE9-481D-AA66-757693D291FB wds:Q34546077-B9DD3BEC-DAFD-4852-8DBB-AC0B99C94CF1 wds:Q34546077-D37DB7CF-2C89-414D-98E4-EB87EFFE7D25
wdt:P2093
D G Kieback R Rosso M Inbar E Grischke CAELYX Breast Cancer Study Group N Wigler F Orlandi L Alland R Catane A Santoro S P Ackland L Mellars P Tomczak C Tendler M E R O'Brien
rdfs:label
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
skos:prefLabel
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl
schema:name
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
p:P50
wds:Q34546077-EC58E341-2DD1-4E97-B09D-9D43B49B01F0
wdt:P50
wd:Q56335956
p:P1476
wds:Q34546077-30AE231E-7FD6-4146-8B57-BA811B049EF4
wdt:P1476
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
p:P304
wds:Q34546077-7EEEDDC8-77AD-45C1-892B-BA842ED2BE00
wdt:P304
440-449
p:P31
wds:Q34546077-8BAC58A1-0FA3-400A-9708-46E626019277
wdt:P31
wd:Q13442814
p:P921
wds:Q34546077-459F26F4-0B05-4E01-81BF-0D208F43CA44 wds:Q34546077-61125F58-3B8F-419C-91E9-3FD89BF95671 wds:Q34546077-679D668C-C574-408D-AE23-4A6E5DF96B70
wdt:P921
wd:Q18936 wd:Q42824827 wd:Q128581
p:P698
wds:Q34546077-2212EC69-7EFA-46F2-BE70-890256FFA4A4
wdtn:P698
n12:14998846
wdt:P698
14998846
p:P1433
wds:Q34546077-1EC832F2-4CD4-4C14-81C1-EB6169FA8CFC
wdt:P1433
wd:Q326122
p:P433
wds:Q34546077-D42D8374-D464-4DD5-9F9B-7F3C187E733C
p:P478
wds:Q34546077-DC119170-8D43-47CA-B6EF-BE01DC0E555A
wdt:P433
3
wdt:P478
15
p:P356
wds:Q34546077-22121CA4-4C14-40D2-9FA8-B15332FFBC77
wdtn:P356
n10:MDH097
wdt:P356
10.1093/ANNONC/MDH097
p:P5875
wds:Q34546077-901B4703-DFE2-4BD5-BA72-FC0BFCFA64AF
wdt:P5875
277687972